Who has invested in Expansion Therapeutics?

Novartis, Sanofi are named among the investors backing Expansion Therapeutics.

Expansion Therapeutics Funding: $135M Raised, Series B

Expansion Therapeutics funding overview

Expansion Therapeutics is based in Boston, MA. Expansion Therapeutics has raised $135M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Expansion Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Novartis, Sanofi. 2 distinct backers are named across the disclosed rounds.

Expansion Therapeutics at a glance

Total raised: $135M
Latest round: Series B
Latest round date: January 2021
Headquarters: Boston, MA
Notable investors: Novartis, Sanofi

Frequently asked about Expansion Therapeutics funding

How much has Expansion Therapeutics raised?: Expansion Therapeutics has raised $135M in total disclosed funding across the rounds on record.
Who has invested in Expansion Therapeutics?: Novartis, Sanofi are named among the investors backing Expansion Therapeutics.
What was the latest Expansion Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2021.
Where is Expansion Therapeutics based?: Expansion Therapeutics is based in Boston, MA.
When did Expansion Therapeutics last raise?: The last disclosed Expansion Therapeutics round closed in January 2021 at Series B.

Round data for Expansion Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.

Expansion Therapeutics Funding: $135M Raised, Series B

Expansion Therapeutics funding overview

Expansion Therapeutics at a glance

Frequently asked about Expansion Therapeutics funding

Companies related to Expansion Therapeutics (36)

Browse related funding lists (7)